封面
市场调查报告书
商品编码
1777258

缺血性中风手术的全球市场:手术类型·产品类型·终端用户·各地区 (~2035年)

Global Ischemic Stroke Surgery Market Research Report by Type of Surgery, by Product Type, by End-User, and by Region Industry Forecast till 2035

出版日期: | 出版商: Market Research Future | 英文 115 Pages | 订单完成后即时交付

价格

全球缺血性中风手术市场预计将从 2021 年的 22.9116 亿美元成长至 2035 年底的 72.6615 亿美元,复合年增长率为 8.70%。

缺血性中风手术是一种清除血栓、恢復脑血流的医疗手段,可以最大限度地减少脑损伤,提高急性缺血性中风患者的康復几率。

缺乏运动和不良的生活习惯正在推动全球缺血性中风手术市场的需求。先进手术技术和设备的引入正在改善治疗效果,越来越多的患者选择微创手术来加速復原。

然而,医疗基础设施不足和熟练医务人员的短缺阻碍了该领域的发展。然而,随着研发和投资的增加,缺血性中风手术市场正在寻找新的发展途径。

区域分析

由于中风病例数量众多以及血管内血栓切除术等尖端技术的广泛应用,北美市场持续快速扩张。推动市场成长的因素包括老龄人口成长、认知度提高以及技术进步。

新的研究和血栓切除术等成功的治疗方法正在推动欧洲市场的成长。由于对医疗创新的大力支持,该地区的卒中治疗效果正在改善。

随着各国政府加大研究和医疗保健支出,亚太市场正快速扩张。在韩国、日本和印度等国家,新的治疗方法越来越普及,帮助患者復原。

在拉丁美洲、中东和非洲,中风相关疾病的发生率呈上升趋势,推动了对手术的需求。更好的医疗基础设施和健康计划支持这些地区全球市场的成长。

本报告研究了全球缺血性中风手术市场,并提供了市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、按各个细分市场、地区和主要国家/地区进行的细分、竞争格局以及主要公司的概况。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 缺乏运动和久坐不动的生活方式日益增多
    • 先进科技产品的采用与推出
    • 微创手术需求不断成长
  • 限制因素
    • 医疗设施短缺
    • 熟练专业人员短缺
  • 机遇
    • 研发活动与投资

第5章 市场要素分析

  • 价值链分析
  • 波特的五力分析
  • COVID-19对全球缺血性中风手术市场带来的影响
  • 流行病学分析
  • 法规分析/医疗制度

第6章 全球缺血性中风手术市场:手术类别

  • 概要
  • 血栓消除术
  • 血管再生手术
  • 颈动脉内薄膜切除术
  • 血管成形术
  • 其他

第7章 全球缺血性中风手术市场:各产品类型

  • 概要
  • 导管
  • 吸引系统
  • 导管导引线
  • 微导管
  • 其他

第8章 全球缺血性中风手术市场:各终端用户

  • 概要
  • 医院·诊疗所
  • 门诊病人手术中心
  • 其他

第9章 全球缺血性中风手术市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他
  • 其他地区
    • 中东
    • 非洲
    • 南美

第10章 竞争情形

  • 概要
  • 市场占有率分析
  • 竞争基准
  • 全球缺血性中风手术市场的关键成长策略
  • 全球缺血性中风手术发展数量排名靠前的顶级公司市场
  • 主要的开发分析
  • 主要的展开·成长策略
  • 财务矩阵

第11章 企业简介

  • MEDTRONIC PLC
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • CORDIS CORPORATION
  • KONINKLIJKE PHILIPS N.V
  • STRYKER
  • IMPERATIVE CARE
  • JOHNSON & JOHNSON SERVICES, INC.
  • PENUMBRA, INC.
  • PHENOXYHENOX GMBH

第12章 附录

Product Code: MRFR/HC/9493-CR

Global Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Industry Forecast till 2035

Industry Overview

The global ischemic stroke surgery market reached USD 2,291.16 million in 2021 and is projected to achieve USD 7,266.15 million with a CAGR of 8.70% by the end of 2035. Ischemic stroke surgery is a medical procedure used to remove blood clots and restore blood flow to the brain. It helps reduce brain damage and improves recovery chances in patients suffering from acute ischemic stroke.

An increase in physical inactivity and poor lifestyle choices is pushing the demand in the global ischemic stroke surgery market. Advanced surgical methods and tools are making treatments more effective. Patients are also choosing less invasive procedures for quicker recovery.

The presence of limited medical infrastructure and a lack of experienced professionals is slowing the progress of the global ischemic stroke surgery industry. Still, with more research and investment, the ischemic stroke surgery market is finding new paths for development.

Industry Segmentations

In terms of product type, the global market is divided into catheters, aspiration systems, guidewires, microcatheters, and others.

Based on the type of surgery, the global ischemic stroke surgery market is classified into Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, and others.

The global ischemic stroke surgery market is segmented based on the end-users, including hospitals and clinics, ambulatory surgical centers, and others.

Regional Analysis

The ischemic stroke surgery market is still expanding rapidly in North America due to a large number of stroke cases and rising utilization of cutting-edge techniques like endovascular thrombectomy. An increasing senior population, more awareness, and technological advancements are all driving market expansion.

New research and successful treatments like thrombectomy are driving the growth of the ischemic stroke surgery market in Europe. The region's stroke treatment results are improving because of strong support for healthcare innovation.

The ischemic stroke surgery market is broadening quickly in the Asia-Pacific as governments increase their spending on research and healthcare. New treatments are becoming more widely available in nations like South Korea, Japan, and India, which is helping patients recover.

Latin America, the Middle East, and Africa are experiencing a rise in stroke-related illnesses, creating a higher demand for surgery. Better medical infrastructure and health programs are helping these regions grow in the global market.

Key Players

Major players in the global ischemic stroke surgery market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Stryker, Imperative Care, Penumbra, Inc., and Phenox GmbH.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
    • 4.2.2 ADOPTION AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
    • 4.2.3 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
  • 4.3 RESTRAINTS
    • 4.3.1 LACK OF MEDICAL FACILITIES
    • 4.3.2 SHORTAGE OF SKILLED PROFESSIONALS
  • 4.4 OPPORTUNITIES
    • 4.4.1 R&D ACTIVITIES AND INVESTMENTS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON PRODUCTION
    • 5.3.3 IMPACT ON DEMAND
  • 5.4 EPIDEMIOLOGY ANALYSIS
    • 5.4.1 INCIDENCE & PREVALENCE
    • 5.4.2 NUMBER OF PROCEDURES FOR THROMBECTOMY
  • 5.5 REGULATORY ANALYSIS/HEALTHCARE SYSTEM

6 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY

  • 6.1 OVERVIEW
  • 6.2 THROMBECTOMY
  • 6.3 REVASCULARIZATION SURGERY
  • 6.4 CAROTID ENDARTERECTOMY
  • 6.5 ANGIOPLASTY
  • 6.6 OTHERS

7 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE

  • 7.1 OVERVIEW
  • 7.2 CATHETER
  • 7.3 ASPIRATION SYSTEM
  • 7.4 GUIDEWIRE
  • 7.5 MICROCATHETER
  • 7.6 OTHERS

8 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS AND CLINICS
  • 8.3 AMBUATORY SURGICAL CENTRES
  • 8.4 OTHERS

9 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
    • 9.4.2 CHINA
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA
    • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANAYISIS
  • 10.3 COMPETITIVE BENCHMARKING
  • 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • 10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • 10.6 KEY DEVELOPMENT ANALYSIS
  • 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.7.1 MERGER & ACQUISITIONS
    • 10.7.2 AGREEMENT/MARKETING STRATEGIES
  • 10.8 FINANCIAL MATRIX
    • 10.8.1 SALES (USD MILLION), 2021
    • 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES

  • 11.1 MEDTRONIC PLC
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS/SERVICES OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 ABBOTT LABORATORIES
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 KEY STRATEGIES
  • 11.3 BOSTON SCIENTIFIC CORPORATION
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 CORDIS CORPORATION
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 KONINKLIJKE PHILIPS N.V
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 STRYKER
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS

1 1.6.6 KEY STRATEGIES

  • 11.7 IMPERATIVE CARE
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 JOHNSON & JOHNSON SERVICES, INC.
    • 11.8.1 COMPANY OVERVIEWS
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 PENUMBRA, INC.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 PHENOXYHENOX GMBH
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY REGION (2021)
  • TABLE 4 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY COUNTRY (2021)
  • TABLE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 6 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR THROMBECTOMY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 7 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR REVASCULARIZATION SURGERY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 8 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 9 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 10 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 11 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 12 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 13 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 14 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 15 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 16 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 17 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 18 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 19 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 20 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018-2035 (USD MILLION)
  • TABLE 21 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035 (USD MILLION)
  • TABLE 22 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
  • TABLE 23 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 24 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 25 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 26 US: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 27 US: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 28 US: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 29 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 30 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 31 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 32 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
  • TABLE 33 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 34 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 35 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 36 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 37 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 38 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 39 UK: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 40 UK: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 41 UK: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 42 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 43 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 44 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 45 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 46 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 47 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 48 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 49 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 50 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 51 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 52 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 53 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
  • TABLE 55 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 56 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 57 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 58 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 59 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 60 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 61 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 62 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 63 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 64 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 65 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 66 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 67 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 68 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 69 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 70 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 71 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 72 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 73 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 74 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 75 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 76 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035(USD MILLION)
  • TABLE 77 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 78 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 79 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 80 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 81 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 82 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 83 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 84 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 85 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 86 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
  • TABLE 87 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
  • TABLE 88 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
  • TABLE 89 MAJOR PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • TABLE 90 MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • TABLE 91 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 92 MERGER & ACQUISITIONS
  • TABLE 93 AGREEMENT/MARKETING STRATEGIES
  • TABLE 94 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 95 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 96 ABBOTT LABORATORIES: KEY DEVELOPMENTS
  • TABLE 97 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 98 CORDIS CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 99 KONINKLIJKE PHILIPS N.V .: PRODUCTS/SERVICES OFFERED
  • TABLE 100 STRYKER: PRODUCTS OFFERED
  • TABLE 101 STRYKER: KEY DEVELOPMENTS
  • TABLE 102 IMPERATIVE CARE: PRODUCTS OFFERED
  • TABLE 103 IMPERATIVE CARE: KEY DEVELOPMENTS
  • TABLE 104 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 105 JOHNSON & JOHNSON SERVICES, INC.: KEY DEVELOPMENTS
  • TABLE 106 PENUMBRA, INC.: PRODUCTS OFFERED
  • TABLE 107 PENUMBRA, INC.: KEY DEVELOPMENTS
  • TABLE 108 PHENOX GMBH: PRODUCTS OFFERED
  • TABLE 109 PHENOX GMBH: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 5 DRIVERS: IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT: IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ISCHEMIC STROKE MARKET
  • FIGURE 1 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2021 & 2035 (USD MILLION)
  • FIGURE 2 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2021 & 2035 (USD MILLION)
  • FIGURE 3 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2021 & 2035 (USD MILLION)
  • FIGURE 4 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION 2021 & 2035 (USD MILLION)
  • FIGURE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION,
  • FIGURE 6 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY
  • FIGURE 7 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
  • FIGURE 8 EUROPE: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY
  • FIGURE 9 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
  • FIGURE 10 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY,
  • FIGURE 11 ASIA PACIFIC ISCHEMIC STROKE SURGERY MARKET SHARE, BY COUNTRY 2021 & 2035 (USD MILLION)
  • FIGURE 12 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION,
  • FIGURE 13 REST OF THE WORLD ISCHEMIC STROKE SURGERY MARKET SHARE, BY REGION 2021 & 2035 (USD MILLION)
  • FIGURE 14 MAJOR MANUFACTURERS MARKET SHARE (%) ANALYSIS,
  • FIGURE 15 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 16 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
  • FIGURE 17 GLOBAL ISCHEMIC STROKE SURGERY MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 18 SALES (USD MILLION),
  • FIGURE 19 RESEARCH & DEVELOPMENT EXPENDITURE
  • FIGURE 20 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 21 MEDTRONIC PLC: SWOT ANALYSIS
  • FIGURE 22 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 23 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 24 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
  • FIGURE 26 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 STRYKER: SWOT ANALYSIS
  • FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 JOHNSON & JOHNSON SERVICES INC.: SWOT ANALYSIS
  • FIGURE 30 PENUMBRA, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 PENUMBRA, INC.: SWOT ANALYSIS